Links to Alpha-1 Antitrysin Deficiency related clinical trials that are planned, have been completed, or are underway in or have relevance to those affected by AATD in Australia.
A Study of Belcesiran in Patients With A1ATD-Associated Liver Disease (ESTRELLA)
By Dicerna Pharmaceuticals, Inc
By Grifols
A Single Ascending and Repeated Dose Study of Oral ZF874 in Healthy Volunteers and PiMZ Subjects
By Z Factor Limited
By Arrowhead Research Corporation
Now Closed
Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor (API) Deficiency
By CSL Behring
Now Closed
Pharmacokinetic Study of Aralast (Human Alpha1- PI)